South San Francisco, CA, United States of America

Noah C Welker

This inventor holds 17 USPTO granted patents and 12 published patent applications and 3 EPO patents, primarily in Circulating Tumor DNA. Top assignees: Myriad Women's Health, Inc., Counsyl, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noah C Welker. Retrieved from https://idiyas.com/inventor/noah-c-welker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 12)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 72(Granted Patents)

Location History:

South San Francisco, CA (US) (2022)
Half Moon Bay, CA (US) (2020 - 2024)

Company Filing History:

16 out of 33

Myriad Women's Health, Inc.

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

Target Polynucleotides

Circulating Tumor DNA

Nucleic Acid Sequencing

DNA Detection

Automated Methods

Combinatorial Screening

Cell-Free DNA

Biological Sample

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692539 - METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET POLYNUCLEOTIDES (2026-07-28),

2. 12545963 - PERSONALIZED METHODS OF DETECTING CIRCULATING TUMOR DNA (2026-02-10),

3. 12534719 - Nucleic acid sequencing adapters and uses thereof (2026-01-27),

4. 12351880 - Methods of detecting and enriching circulating tumor DNA (2025-07-08),

5. 12351879 - Enrichment of circulating tumor DNA (2025-07-08),

6. 12344901 - Automated methods of detecting cell free DNA (2025-07-01),

7. 12270082 - Methods of detecting DNA in a sample (2025-04-08),

8. 12215392 - Methods of preparing a DNA fraction enriched with circulating tumor DNA (2025-02-04),

9. 12215391 - Automated methods of detecting cell free DNA (2025-02-04),

10. 12104212 - Personalized methods for detecting circulating tumor DNA (2024-10-01),

11. 12024749 - Combinatorial DNA screening (2024-07-02),

12. 11932910 - Combinatorial DNA screening (2024-03-19),

13. 11708574 - Nucleic acid sequencing adapters and uses thereof (2023-07-25),

14. 11339431 - Methods and compositions for enrichment of target polynucleotides (2022-05-24),

15. 11326158 - Enrichment of cell-free DNA from a biological sample (2022-05-10),

Title: Innovator Spotlight: Noah C. Welker

Introduction

Noah C. Welker is a talented inventor based in South San Francisco, California, with a keen focus on advancements in genetic testing and molecular diagnostics. With a portfolio of 11 patents, Welker is making significant strides in the field of biotechnology, contributing innovative solutions that enhance our understanding of genetics and disease detection.

Latest Patents

Among his notable inventions are methods for detecting DNA in samples. This innovative approach involves identifying unique genetic signatures derived from mutations in nucleic acids obtained from biological materials. The sensitivity of these methods allows for the detection of mutations related to diseases such as cancer or inherited disorders in a noninvasive manner, even at extremely low proportions of mutated sequences. Additionally, he has developed automated methods for detecting cell-free DNA, utilizing a laboratory execution system that streamlines laboratory processes through automation. This system dynamically updates and manages laboratory components, assisting with complex analytical functions that enhance the detection of specific molecules of interest.

Career Highlights

Noah is currently employed at Myriad Women's Health, Inc., a company dedicated to advancing healthcare through personalized genetic testing and diagnostics. His work contributes to the company's mission of improving patient outcomes by leveraging cutting-edge genetic technology.

Collaborations

Throughout his career, Welker has collaborated with esteemed colleagues, including Clement S. Chu and Imran Saeedul Haque. Their collective expertise and innovative spirit have fostered an environment of discovery and advancement in the realm of genetics.

Conclusion

Noah C. Welker exemplifies the spirit of innovation within the field of biotechnology. His contributions are vital in shaping the future of genetic testing and disease detection. As he continues to develop transformative technologies, he remains a key figure in advancing healthcare solutions for patients worldwide.

Profile summary based on public USPTO records.